Safety and Tolerability of Gefapixant (MK-7264) in Participants With Obstructive Sleep Apnea (MK-7264-039)

Clinical trial NCT03882801 · COMPLETED

Trial details

NCT number: NCT03882801
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Obstructive Sleep Apnea (OSA)

Start date: 2019-04-10
Primary completion: 2019-10-22
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.